Triple-negative breast cancer accounts for approximately 15% of all breast cancer cases. It is characterized by the absence of estrogen receptor, progesterone receptor, and HER2 expression, rendering it insensitive to…

Scientists have combined Artificial Intelligence (AI), genetics and gut microbiome analysis to shed new light on one of the most serious complications of Crohn's disease: intestinal fibrosis, the irreversible scarring…

Researchers from Children's Hospital of Philadelphia (CHOP) have found that pediatric-onset rheumatic and inflammatory diseases have distinct genetic architecture compared with adults.

Insilico Medicine, a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, today announced the nomination of ISM0900, a potent, AI-driven, highly selective, orally available small molecule inhibitor of lipoprotein(a), or…

Ultra-processed foods (UPFs) account for nearly 60% of adults' and 70% of children's energy intake in the United States.

In collaboration with the University of Vienna, the Technical University of Munich (TUM), and Heidelberg University, researchers at the TUD Dresden University of Technology have developed an innovative tool that…

A Case Western Reserve University–led research team is developing a noninvasive oral cancer test to help clinicians decide-chairside and within minutes- whether a suspicious lesion in the mouth needs a…

The Louisiana Breast and Cervical Health Program (LBCHP), a program of the LSU LCMC Health Cancer Center and housed at the LSU Health New Orleans School of Public Health, has…

CN Bio, a leading provider of Organ-on-a-chip (OOC) Systems and solutions that accelerate drug discovery and development workflows, today announced it has been awarded £180 k grant funding from Innovate…

When it comes to identifying harmful bacteria, it helps to look at the company their genes keep.